Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
AI Maverick Intel, Inc., an AI company, focuses on acquiring and enhancing businesses through its proprietary AI Maverick platform. Its technology streamlines the customer acquisition process by automating two way communication and data-driven engagement with its clients ideal audience segments across healthcare, biotech, and other sectors. The company was formerly known as Bionoid Pharma Inc. and changed its name to AI Maverick Intel, Inc. in April 2025. AI Maverick Intel, Inc. was incorporated in 2006 and is based in Beverly Hills, California.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is undervalued on EV/EBITDA.